首页> 外文期刊>Proteins: Structure, Function, and Genetics >Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1.
【24h】

Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1.

机译:了解神经氨酸酶亚型N1催化口袋中已知的药物-靶标相互作用。

获取原文
获取原文并翻译 | 示例
           

摘要

To provide detailed information and insight into the drug-target interaction, structure, solvation, and dynamic and thermodynamic properties, the three known-neuraminidase inhibitors-oseltamivir (OTV), zanamivir (ZNV), and peramivir (PRV)-embedded in the catalytic site of neuraminidase (NA) subtype N1 were studied using molecular dynamics simulations. In terms of ligand conformation, there were major differences in the structures of the guanidinium and the bulky groups. The atoms of the guanidinium group of PRV were observed to form many more hydrogen bonds with the surrounded residues and were much less solvated by water molecules, in comparison with the other two inhibitors. Consequently, D151 lying on the 150-loop (residues 147-152) of group-1 neuraminidase (N1, N4, N5, and N8) was considerably shifted to form direct hydrogen bonds with the --OH group of the PRV, which was located rather far from the 150-loop. For the bulky group, direct hydrogen bonds were detected only between the hydrophilic sidechain of ZNV and residues R224, E276, and E277 of N1 with rather weak binding, 20-70% occupation. This is not the case for OTV and PRV, in which flexibility and steric effects due to the hydrophobic side chain lead to the rearrangement of the surrounded residues, that is, the negatively charged side chain of E276 was shifted and rotated to form hydrogen bonds with the positively charged moiety of R224. Taking into account all the ligand-enzyme interaction data, the gas phase MM interaction energy of -282.2 kcal/mol as well as the binding free energy (DeltaG(binding)) of -227.4 kcal/mol for the PRV-N1 are significantly lower than those of the other inhibitors. The ordering of DeltaG(binding) of PRV < ZNV < OTV agrees well with the ordering of experimental IC(50) value.
机译:为了提供有关药物-靶标相互作用,结构,溶剂化以及动态和热力学性质的详细信息和见解,将三种已知的神经氨酸酶抑制剂-奥司他韦(OTV),扎那米韦(ZNV)和帕拉米韦(PRV)嵌入了催化使用分子动力学模拟研究了神经氨酸酶(NA)亚型N1的位点。就配体构象而言,胍基和大基团的结构存在主要差异。与其他两种抑制剂相比,已观察到PRV的胍基原子与周围的残基形成更多的氢键,并且被水分子的溶剂化程度降低。因此,位于第1组神经氨酸酶(N1,N4,N5和N8)的150个环(残基147-152)上的D151大量移位,与PRV的--OH基团形成直接氢键。距离150回路很远。对于庞大的基团,仅在ZNV的亲水性侧链与N1的残基R224,E276和E277之间具有很弱的结合(占20-70%的占有率)之间检测到直接氢键。对于OTV和PRV并非如此,其中由于疏水性侧链而引起的柔韧性和空间效应会导致周围残基的重排,即E276的带负电荷的侧链发生移位并旋转以形成氢键, R224的带正电荷的部分。考虑到所有的配体-酶相互作用数据,PRV-N1的气相MM相互作用能为-282.2 kcal / mol,结合自由能(DeltaG(binding))为-227.4 kcal / mol比其他抑制剂的PRV

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号